APPENDIX 2

APPENDIX 2

Public hearings and witnesses

Thursday, 21 July 2011

Committee Room G6, Victorian Parliament House, Melbourne

Witnesses

Deakin University

Ms Liliana Bulfone, Senior Research Fellow
Ms Sandra Younie, Senior Research Fellow

Generic Medicines Industry Association

Ms Kate Lynch, Chief Executive Officer
Mr Robert Ellis, Board Member

Allergan Australia

Mr Mark Glover, Vice-President and Managing Director
Mr Duncan O'Brien, Market Access Director

AstraZeneca Australia

Mr Jose Vieira, Managing Director
Dr Simon Fisher, Medical Director

Janssen-Cilag Australia

Mr Bruce Goodwin, Managing Director
Professor Jayashri Kulkarni, Professor of Psychiatry, Faculty of Medicine, Monash University

Mundipharma

Mr Rob Baveystock, Managing Director
Dr John Whitlam, Medical Affairs Director

Pfizer Australia

Mr John Latham, Managing Director
Dr Bill Ketelbey, Country Medical Director

Ms Elizabeth Trapani and Ms Chey-Anne Ellsum

MS Australia

Mr Robert Pask, Coordinator, National Advocacy Program

Chronic Illness Alliance

Dr Christine Walker, Chief Executive Officer

Australian Pain Management Association

Mr Paul Murdoch, Vice-President

Painaustralia

Professor Michael Cousins, Director

National Association of People Living with HIV/AIDS

Mr David Menadue, Special Representative 

Monday, 25 July 2011

Committee Room 2S1, Parliament House, Canberra

Witnesses

Department of Health and Ageing

Mr David Learmonth, Deputy Secretary
Ms Felicity McNeill, A/g First Assistant Secretary, Pharmaceutical Benefits Division
Ms Adriana Platona, Assistant Secretary, Pharmaceutical Evaluation Branch

Department of Finance and Deregulation

Mr David Martine, Deputy Secretary, Budget Group
Mr David de Carvalho, First Assistant Secretary, Social Policy Division, Budget Group

Pharmaceutical Benefits Advisory Committee

Emeritus Professor Lloyd Sansom, Chair

Medicines Australia

Dr Brendan Shaw, Chief Executive
Mr Andrew Bruce, Director, Health Policy and Research

Consumers Health Forum of Australia

Ms Carol Bennett, Chief Executive Officer
Ms Anna Wise, Senior Policy Manager

Cancer Voices Australia

Mr John Stubbs, Executive Officer

Brain Tumour Alliance Australia

Mr Matthew Pitt, Chair
Mr Denis Strangman, Secretary
Ms Renee Hindson, Member

SANE Australia

Ms Barbara Hocking, Executive Director

Hepatitis Australia

Ms Helen Tyrrell, Chief Executive Officer 

Navigation: Previous Page | Contents